Title
Category
Credits
Event date
Cost
$0.00
Learn how to apply the 2022 Clinical Practice Guideline to effectively manage patients in the emergency department setting who present with pain or opioid-related adverse events, such as overdose or opioid use disorder (OUD).WB4713
  • Pain Manag...See more
$0.00
This educational activity is designed to educate and equip healthcare professionals with the clinical decision-making skills to determine whether to initiate or continue opioid therapy.
  • Pain Manag...See more
  • Pain Management: Opioid(s)
  • 1.00 AAPA Category I CME
$0.00
This series of videos is aimed at helping you engage in successful pain management telehealth visits with your patients. Clinicians may have had little to no training on the communication and clinical skills needed for telehealth patient encounters. Most have never learned how to “see” a patient on video during medical training. Our goal for this education is to help you improve your pain management telehealth visits. We’re going to cover some telehealth tips that will help make you successful and keep your patient engaged.
  • Pain Manag...See more
  • 2.00 AAPA Category I CME
$0.00
Healthcare providers who prescribe opioid analgesics have a responsibility to help ensure the safe and effective use of opioid analgesics. This educational initiative is intended for PAs involved in the care of patients with chronic pain, focuses on the safe and prescribing of opioid analgesics and meets the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
  • Buprenorph...See more
  • Opioid Use Disorder (OUD)
  • Pain Management
  • 1.00 AMA PRA Category 1 Credit
$0.00
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Dr. Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr.